NCT03123601 is a NA clinical trial of Risk sign displays in Nursing Home Residents, sponsored by Campus Neurológico Sénior.

Who is sponsoring NCT03123601?

NCT03123601 is sponsored by Campus Neurológico Sénior.

What drugs are being tested in NCT03123601?

Interventions in NCT03123601: Risk sign displays.

What condition does NCT03123601 study?

NCT03123601 studies Nursing Home Residents.

Is NCT03123601 still recruiting?

NCT03123601 is currently completed. Last updated 21 March 2019.

Last reviewed 2019-03-21 · How we verify

NCT03123601

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes

Completed NA Last updated 21 March 2019

What this trial tests

NA trial testing Risk sign displays in Nursing Home Residents in 20 participants. Completed in 30 May 2017.

Timeline

1 November 2016

Primary endpoint
30 April 2017

30 May 2017

Quick facts

Lead sponsor	Campus Neurológico Sénior
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	20
Start date	1 November 2016
Primary completion	30 April 2017
Estimated completion	30 May 2017
Sites	1 location across Portugal

Drugs / interventions tested

Risk sign displays

Conditions studied

Nursing Home Residents — all drugs for Nursing Home Residents →

Sponsor

Campus Neurológico Sénior

Who can join

Eligibility, any sex, with Nursing Home Residents. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

BACKGROUND: Prior research has shown a relationship between dehydration, falls and pulmonary aspiration among older adults in nursing and health care facilities, which contributes to its loss of independence and quality-of-life. Is believed that improving communication among health professional decreases the number of adverse events in institutionalized patients. This study will evaluate the feasibility of a set of sign displays designed to communicate fall, dehydration and pulmonary aspiration risks and will reflect on tailored interventions to manage these events in nursing homes. METHODS AND ANALYSIS: This will be a national, single-center, feasibility study. All patients, with chronic neurologic diseases selected from a nursing home, will be invited to participate. At baseline patients will undertake a screening risk assessment and it will be attributed a correspondent risk display. Study duration will be a minimum of 3 months per participant, including daily record of events and monthly interview assessments. Events data will be compared with historical data extracted retrospectively from medical and nursing charts.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility of using risk prompts to prevent falls, dehydration and pulmonary aspiration in nursing homes: a clinical study protocol.
Duarte M, Bouça-Machado R, Domingos J, Godinho C, et al · · 2018 · cited 2× · PMID 29416872 · DOI 10.1186/s40814-018-0236-1

Verify or expand the search:

Other recruiting trials for Nursing Home Residents

Currently open trials in the same condition.

NCT06731361 — Improved Prescribing for Older Nursing Home Patients · NA · recruiting

Other Campus Neurológico Sénior trials

Trials by the same sponsor.

NCT06052930 — Immersive Virtual Reality for the Non-pharmacological Management of Parkinson's Disease · NA · completed
NCT04699617 — The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients · NA · completed
NCT03891069 — Feasibility of the AHA Exergame System in Parkinson's Disease Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03123601 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Campus Neurológico Sénior
Last refreshed: 21 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03123601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing